{"transactions":[{"id":4620410,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-17T01:13:38.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":9.1,"value":45500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 06-15-2026"}],"balance_after":54750,"source":{"system":"sec-edgar","filing":"0001437749-26-030597","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000143774926030597/rdgdoc.xml","form_type":"4"}},{"id":677294,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-24T21:30:03.000Z","date":"2026-08-24","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":12.39,"value":1239000.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $11.47 to $12.85. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":479194,"source":{"system":"sec-edgar","filing":"0001193125-26-363812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526363812/ownership.xml","form_type":"4"}},{"id":685351,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-17T20:45:03.000Z","date":"2026-08-17","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":11.12,"value":1112000.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $10.87 to $11.31. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":379194,"source":{"system":"sec-edgar","filing":"0001193125-26-354201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526354201/ownership.xml","form_type":"4"}},{"id":737667,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:16:34.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":10800,"price":7.1989,"value":77748.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-12-2025"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":59750,"source":{"system":"sec-edgar","filing":"0001437749-26-020709","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020709/rdgdoc.xml","form_type":"4"}},{"id":737666,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:16:34.000Z","date":"2026-06-11","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":70550,"source":{"system":"sec-edgar","filing":"0001437749-26-020709","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020709/rdgdoc.xml","form_type":"4"}},{"id":828179,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-25T13:00:03.000Z","date":"2026-03-23","kind":"exercise","planned":false,"acquired":true,"shares":6103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.15,"expiration_date":"2027-01-22","underlying":"Common Stock","underlying_shares":6103},"source":{"system":"sec-edgar","filing":"0001193125-26-122938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526122938/ownership.xml","form_type":"4"}},{"id":828178,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-25T13:00:03.000Z","date":"2026-03-23","kind":"exercise","planned":false,"acquired":true,"shares":6103,"price":6.15,"value":37533.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options exercised."}],"balance_after":435456,"source":{"system":"sec-edgar","filing":"0001193125-26-122938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526122938/ownership.xml","form_type":"4"}},{"id":873524,"issuer":{"id":6185,"kind":"organization","name":"Atrium Therapeutics, Inc.","symbol":"RNA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-02T23:00:05.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on February 27, 2026 and the shares underlying the options vest in equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":14.75,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-085920","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000119312526085920/ownership.xml","form_type":"4"}},{"id":876611,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T20:15:25.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":26.09,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-082251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000119312526082251/ownership.xml","form_type":"4"}},{"id":876610,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T20:15:25.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":39.96,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":13489},"source":{"system":"sec-edgar","filing":"0001193125-26-082251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000119312526082251/ownership.xml","form_type":"4"}},{"id":876609,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T20:15:25.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10034,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":33.62,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001193125-26-082251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000119312526082251/ownership.xml","form_type":"4"}},{"id":876608,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T20:15:25.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13711,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the \"Merger Agreement\"), among Novartis AG (\"Novartis\"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the \"Merger Agreement\"), among Novartis AG (\"Novartis\"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-082251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000119312526082251/ownership.xml","form_type":"4"}},{"id":876607,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T20:15:25.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65091,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the \"Merger Agreement\"), among Novartis AG (\"Novartis\"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the \"Merger Agreement\"), among Novartis AG (\"Novartis\"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-082251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000119312526082251/ownership.xml","form_type":"4"}},{"id":946216,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T21:31:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":1120000,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":1120000},"source":{"system":"sec-edgar","filing":"0001193125-26-004580","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004580/ownership.xml","form_type":"4"}},{"id":998806,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:10.000Z","date":"2025-11-13","kind":"grant","planned":false,"acquired":true,"shares":182500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 1/3rd of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":429353,"source":{"system":"sec-edgar","filing":"0001193125-25-283565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283565/ownership.xml","form_type":"4"}},{"id":1031157,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:04.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":36615,"price":8.9422,"value":327418.653,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":246853,"source":{"system":"sec-edgar","filing":"0001193125-25-223663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223663/ownership.xml","form_type":"4"}},{"id":1031156,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:04.000Z","date":"2025-09-27","kind":"grant","planned":false,"acquired":true,"shares":182500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":283468,"source":{"system":"sec-edgar","filing":"0001193125-25-223663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223663/ownership.xml","form_type":"4"}},{"id":1044588,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-09T21:53:21.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":false,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":12.48,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001599901-25-000177","document":"wk-form4_1757454797.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000177/wk-form4_1757454797.xml","form_type":"4"}},{"id":1044587,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-09T21:53:21.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":50,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":54425,"source":{"system":"sec-edgar","filing":"0001599901-25-000177","document":"wk-form4_1757454797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000177/wk-form4_1757454797.xml","form_type":"4"}},{"id":1044586,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-09T21:53:21.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":14500,"price":50,"value":725000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":69425,"source":{"system":"sec-edgar","filing":"0001599901-25-000177","document":"wk-form4_1757454797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000177/wk-form4_1757454797.xml","form_type":"4"}},{"id":1044585,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-09T21:53:21.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":true,"shares":14500,"price":12.48,"value":180960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":83925,"source":{"system":"sec-edgar","filing":"0001599901-25-000177","document":"wk-form4_1757454797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000177/wk-form4_1757454797.xml","form_type":"4"}},{"id":1044723,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-09-09T20:28:40.000Z","date":"2025-09-08","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":8.2029,"value":410145.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $8.135 to $8.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakesto provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":100968,"source":{"system":"sec-edgar","filing":"0001415889-25-023974","document":"form4-09092025_080937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000141588925023974/form4-09092025_080937.xml","form_type":"4"}},{"id":1066314,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-14T20:05:05.000Z","date":"2025-08-13","kind":"purchase","planned":false,"acquired":true,"shares":13494,"price":6.6417,"value":89623.0998,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $6.485 to $6.735. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":50968,"source":{"system":"sec-edgar","filing":"0000950170-25-108844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025108844/ownership.xml","form_type":"4"}},{"id":1066313,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-14T20:05:05.000Z","date":"2025-08-12","kind":"purchase","planned":false,"acquired":true,"shares":36506,"price":5.8505,"value":213578.353,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $5.56 to $5.995. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 409 shares acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":37474,"source":{"system":"sec-edgar","filing":"0000950170-25-108844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025108844/ownership.xml","form_type":"4"}},{"id":1071119,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-08T21:42:43.000Z","date":"2025-08-06","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of common stock subject to this option were fully vested and exercisable as of the date of execution of this option by Reporting Person."}],"balance_after":14500,"derivative":{"exercise_price":12.48,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001599901-25-000154","document":"wk-form4_1754689360.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000154/wk-form4_1754689360.xml","form_type":"4"}},{"id":1071118,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-08T21:42:43.000Z","date":"2025-08-06","kind":"exercise","planned":true,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of common stock subject to this option were fully vested and exercisable as of the date of execution of this option by Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":12.03,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001599901-25-000154","document":"wk-form4_1754689360.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000154/wk-form4_1754689360.xml","form_type":"4"}},{"id":1071117,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T21:42:43.000Z","date":"2025-08-06","kind":"sale","planned":true,"acquired":false,"shares":17777,"price":45,"value":799965.0,"ownership":{"direct":false,"nature":"By irrevocable trust 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":17776,"source":{"system":"sec-edgar","filing":"0001599901-25-000154","document":"wk-form4_1754689360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000154/wk-form4_1754689360.xml","form_type":"4"}},{"id":1071116,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T21:42:43.000Z","date":"2025-08-06","kind":"sale","planned":true,"acquired":false,"shares":17777,"price":45,"value":799965.0,"ownership":{"direct":false,"nature":"By irrevocable trust 3"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":17776,"source":{"system":"sec-edgar","filing":"0001599901-25-000154","document":"wk-form4_1754689360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000154/wk-form4_1754689360.xml","form_type":"4"}},{"id":1071115,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T21:42:43.000Z","date":"2025-08-06","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":45,"value":675000.0,"ownership":{"direct":false,"nature":"By irrevocable trust 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":285000,"source":{"system":"sec-edgar","filing":"0001599901-25-000154","document":"wk-form4_1754689360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000154/wk-form4_1754689360.xml","form_type":"4"}},{"id":1071114,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T21:42:43.000Z","date":"2025-08-06","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":45,"value":675000.0,"ownership":{"direct":false,"nature":"By irrevocable trust 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":285000,"source":{"system":"sec-edgar","filing":"0001599901-25-000154","document":"wk-form4_1754689360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000154/wk-form4_1754689360.xml","form_type":"4"}},{"id":1071113,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T21:42:43.000Z","date":"2025-08-06","kind":"sale","planned":true,"acquired":false,"shares":7500,"price":45,"value":337500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":69425,"source":{"system":"sec-edgar","filing":"0001599901-25-000154","document":"wk-form4_1754689360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000154/wk-form4_1754689360.xml","form_type":"4"}},{"id":1071112,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T21:42:43.000Z","date":"2025-08-06","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":12.48,"value":93600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":76925,"source":{"system":"sec-edgar","filing":"0001599901-25-000154","document":"wk-form4_1754689360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000154/wk-form4_1754689360.xml","form_type":"4"}},{"id":1071111,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T21:42:43.000Z","date":"2025-08-06","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":45,"value":990000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":69425,"source":{"system":"sec-edgar","filing":"0001599901-25-000154","document":"wk-form4_1754689360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000154/wk-form4_1754689360.xml","form_type":"4"}},{"id":1071110,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-08T21:42:43.000Z","date":"2025-08-06","kind":"exercise","planned":true,"acquired":true,"shares":22000,"price":12.03,"value":264660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024."}],"balance_after":91425,"source":{"system":"sec-edgar","filing":"0001599901-25-000154","document":"wk-form4_1754689360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000154/wk-form4_1754689360.xml","form_type":"4"}},{"id":1107819,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T23:55:12.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":10800,"price":3.4,"value":36720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03/12/2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":43550,"source":{"system":"sec-edgar","filing":"0001437749-25-020721","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020721/rdgdoc.xml","form_type":"4"}},{"id":1111408,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:11:24.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":54350,"source":{"system":"sec-edgar","filing":"0001437749-25-020358","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020358/rdgdoc.xml","form_type":"4"}},{"id":1112895,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T22:26:06.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":10034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full on the first to occur of June 10, 2026 or the Issuer's 2026 annual meeting of stockholders, in each case subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":10034,"derivative":{"exercise_price":33.62,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001599901-25-000119","document":"wk-form4_1749767160.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000119/wk-form4_1749767160.xml","form_type":"4"}},{"id":1112894,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T22:26:06.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":6692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full on the first to occur of June 10, 2026 or the Issuer's 2026 annual meeting of stockholders, in each case subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":69425,"source":{"system":"sec-edgar","filing":"0001599901-25-000119","document":"wk-form4_1749767160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990125000119/wk-form4_1749767160.xml","form_type":"4"}},{"id":1310321,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2025-01-06T21:05:20.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":625000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":625000,"derivative":{"exercise_price":8.68,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0000950170-25-002046","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025002046/ownership.xml","form_type":"4"}},{"id":1471918,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:27:25.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":27350,"source":{"system":"sec-edgar","filing":"0001437749-24-021024","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021024/rdgdoc.xml","form_type":"4"}},{"id":1477155,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-17T23:27:35.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":3.3297,"value":89901.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2801 to $3.5801, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":350,"source":{"system":"sec-edgar","filing":"0001437749-24-020574","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924020574/rdgdoc.xml","form_type":"4"}},{"id":1478498,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:52:23.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":13489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":13489,"derivative":{"exercise_price":39.96,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":13489},"source":{"system":"sec-edgar","filing":"0001599901-24-000087","document":"wk-form4_1718405536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990124000087/wk-form4_1718405536.xml","form_type":"4"}},{"id":1669457,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-26T22:10:05.000Z","date":"2024-01-24","kind":"sale","planned":false,"acquired":false,"shares":84107,"price":20.23,"value":1701484.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022."}],"balance_after":559,"source":{"system":"sec-edgar","filing":"0000950170-24-008020","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024008020/ownership.xml","form_type":"4"}},{"id":1669456,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-26T22:10:05.000Z","date":"2024-01-24","kind":"exercise","planned":false,"acquired":true,"shares":84107,"price":6.15,"value":517258.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022."}],"balance_after":84666,"source":{"system":"sec-edgar","filing":"0000950170-24-008020","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024008020/ownership.xml","form_type":"4"}},{"id":1669455,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-26T22:10:05.000Z","date":"2024-01-24","kind":"sale","planned":false,"acquired":false,"shares":6945,"price":20.23,"value":140497.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022."}],"balance_after":559,"source":{"system":"sec-edgar","filing":"0000950170-24-008020","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024008020/ownership.xml","form_type":"4"}},{"id":1669454,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-26T22:10:05.000Z","date":"2024-01-24","kind":"exercise","planned":false,"acquired":true,"shares":6945,"price":4.8,"value":33336.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2022."}],"balance_after":7504,"source":{"system":"sec-edgar","filing":"0000950170-24-008020","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024008020/ownership.xml","form_type":"4"}},{"id":1687546,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2024-01-04T21:06:02.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":560000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":560000,"derivative":{"exercise_price":15.36,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":560000},"source":{"system":"sec-edgar","filing":"0000950170-24-001842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024001842/ownership.xml","form_type":"4"}},{"id":1710644,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-14T11:50:54.000Z","date":"2023-12-12","kind":"other","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By trust FBO Children 3 and 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer for no value from the Reporting Person to a trust established for the benefit of the Reporting Person's family."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001599901-23-000101","document":"wk-form4_1702554646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990123000101/wk-form4_1702554646.xml","form_type":"4"}},{"id":1710643,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-14T11:50:54.000Z","date":"2023-12-12","kind":"other","planned":false,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer for no value from the Reporting Person to a trust established for the benefit of the Reporting Person's family."}],"balance_after":13711,"source":{"system":"sec-edgar","filing":"0001599901-23-000101","document":"wk-form4_1702554646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990123000101/wk-form4_1702554646.xml","form_type":"4"}},{"id":1710642,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-14T11:50:54.000Z","date":"2023-12-12","kind":"other","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By trust FBO Children 1 and 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer for no value from the Reporting Person to a trust established for the benefit of the Reporting Person's family."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001599901-23-000101","document":"wk-form4_1702554646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990123000101/wk-form4_1702554646.xml","form_type":"4"}},{"id":1710641,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-14T11:50:54.000Z","date":"2023-12-12","kind":"other","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer for no value from the Reporting Person to a trust established for the benefit of the Reporting Person's family."}],"balance_after":263711,"source":{"system":"sec-edgar","filing":"0001599901-23-000101","document":"wk-form4_1702554646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990123000101/wk-form4_1702554646.xml","form_type":"4"}},{"id":1716207,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-11T21:08:59.000Z","date":"2023-12-07","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"balance_after":279194,"source":{"system":"sec-edgar","filing":"0001209191-23-058040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123058040/doc4.xml","form_type":"4"}},{"id":1716206,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-11T21:08:59.000Z","date":"2023-12-07","kind":"gift","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":559,"source":{"system":"sec-edgar","filing":"0001209191-23-058040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123058040/doc4.xml","form_type":"4"}},{"id":1848849,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T20:07:37.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":22000,"derivative":{"exercise_price":12.48,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001599901-23-000050","document":"wk-form4_1687291647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000159990123000050/wk-form4_1687291647.xml","form_type":"4"}},{"id":1854155,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-16T01:14:01.000Z","date":"2023-06-13","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":27350,"source":{"system":"sec-edgar","filing":"0001437749-23-017612","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923017612/rdgdoc.xml","form_type":"4"}},{"id":1854154,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-16T01:14:01.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":3.4544,"value":93268.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":350,"source":{"system":"sec-edgar","filing":"0001437749-23-017612","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923017612/rdgdoc.xml","form_type":"4"}},{"id":1869506,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T21:06:28.000Z","date":"2023-06-02","kind":"other","planned":false,"acquired":false,"shares":27966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person.  As a consequence of this transfer, the reporting person will no longer have beneficial ownership of the shares."}],"balance_after":2559,"source":{"system":"sec-edgar","filing":"0001209191-23-033892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033892/doc4.xml","form_type":"4"}},{"id":1869505,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T21:06:28.000Z","date":"2023-06-02","kind":"other","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Lorax Charitable Remainder Unitrust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001209191-23-033892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033892/doc4.xml","form_type":"4"}},{"id":1869504,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T21:06:28.000Z","date":"2023-06-02","kind":"other","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person."}],"balance_after":280194,"source":{"system":"sec-edgar","filing":"0001209191-23-033892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033892/doc4.xml","form_type":"4"}},{"id":1869503,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T21:06:28.000Z","date":"2023-06-02","kind":"other","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person.  As a consequence of this transfer, the reporting person will no longer have beneficial ownership of the shares."}],"balance_after":580194,"source":{"system":"sec-edgar","filing":"0001209191-23-033892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033892/doc4.xml","form_type":"4"}},{"id":1869502,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T21:06:28.000Z","date":"2023-06-02","kind":"other","planned":false,"acquired":false,"shares":212500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person.  As a consequence of this transfer, the reporting person will no longer have beneficial ownership of the shares."}],"balance_after":880194,"source":{"system":"sec-edgar","filing":"0001209191-23-033892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033892/doc4.xml","form_type":"4"}},{"id":1869501,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T21:06:28.000Z","date":"2023-06-02","kind":"other","planned":false,"acquired":false,"shares":41318,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person.  As a consequence of this transfer, the reporting person will no longer have beneficial ownership of the shares."}],"balance_after":1092694,"source":{"system":"sec-edgar","filing":"0001209191-23-033892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033892/doc4.xml","form_type":"4"}},{"id":1869500,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T21:06:28.000Z","date":"2023-06-02","kind":"other","planned":false,"acquired":true,"shares":8394,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person."}],"balance_after":1134012,"source":{"system":"sec-edgar","filing":"0001209191-23-033892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033892/doc4.xml","form_type":"4"}},{"id":1869499,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-02T21:06:28.000Z","date":"2023-06-02","kind":"other","planned":false,"acquired":false,"shares":8394,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Red Fish Blue Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-033892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033892/doc4.xml","form_type":"4"}},{"id":2003301,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2023-02-21T22:04:41.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":560000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":560000,"derivative":{"exercise_price":11.99,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":560000},"source":{"system":"sec-edgar","filing":"0001209191-23-011276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011276/doc4.xml","form_type":"4"}},{"id":2003300,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-21T22:04:41.000Z","date":"2022-08-19","kind":"other","acquired":false,"shares":11985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were transferred to the reporting person's former spouse pursuant to a divorce settlement. The securities owned by the former spouse are not beneficially owned by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,109 shares acquired on November 17, 2021 and 1,450 shares acquired on May 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":30525,"source":{"system":"sec-edgar","filing":"0001209191-23-011276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011276/doc4.xml","form_type":"4"}},{"id":2003299,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-21T22:04:41.000Z","date":"2022-10-06","kind":"other","acquired":true,"shares":1084300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another grantor trust established by the reporting person."}],"balance_after":1125618,"source":{"system":"sec-edgar","filing":"0001209191-23-011276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011276/doc4.xml","form_type":"4"}},{"id":2003298,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-21T22:04:41.000Z","date":"2022-10-06","kind":"other","acquired":false,"shares":1084300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Red Fish Blue Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another grantor trust established by the reporting person."}],"balance_after":8394,"source":{"system":"sec-edgar","filing":"0001209191-23-011276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011276/doc4.xml","form_type":"4"}},{"id":2003297,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-21T22:04:41.000Z","date":"2022-08-19","kind":"other","acquired":true,"shares":41318,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by One Fish Two Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another grantor trust established by the reporting person."}],"balance_after":41318,"source":{"system":"sec-edgar","filing":"0001209191-23-011276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011276/doc4.xml","form_type":"4"}},{"id":2003296,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-21T22:04:41.000Z","date":"2022-08-19","kind":"other","acquired":false,"shares":41318,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Red Fish Blue Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another grantor trust established by the reporting person."}],"balance_after":1092694,"source":{"system":"sec-edgar","filing":"0001209191-23-011276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011276/doc4.xml","form_type":"4"}},{"id":2003295,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-21T22:04:41.000Z","date":"2022-08-19","kind":"other","acquired":false,"shares":17708,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Red Fish Blue Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were transferred to the reporting person's former spouse pursuant to a divorce settlement. The securities owned by the former spouse are not beneficially owned by the reporting person."}],"balance_after":1134012,"source":{"system":"sec-edgar","filing":"0001209191-23-011276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011276/doc4.xml","form_type":"4"}},{"id":2003294,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-21T22:04:41.000Z","date":"2022-07-14","kind":"other","acquired":false,"shares":468297,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Red Fish Blue Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were transferred to the reporting person's former spouse pursuant to a divorce settlement. The securities owned by the former spouse are not beneficially owned by the reporting person."}],"balance_after":1151720,"source":{"system":"sec-edgar","filing":"0001209191-23-011276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011276/doc4.xml","form_type":"4"}},{"id":2225264,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-21T23:12:17.000Z","date":"2022-06-16","kind":"sale","acquired":false,"shares":27858,"price":2.5835,"value":71971.143,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.544 to $2.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":27350,"source":{"system":"sec-edgar","filing":"0001437749-22-015529","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922015529/rdgdoc.xml","form_type":"4"}},{"id":2226690,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-18T00:52:38.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":22000,"derivative":{"exercise_price":12.03,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-22-038222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000120919122038222/doc4.xml","form_type":"4"}},{"id":2229836,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-16T22:49:49.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":55208,"source":{"system":"sec-edgar","filing":"0001437749-22-015210","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922015210/rdgdoc.xml","form_type":"4"}},{"id":2422414,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2022-01-28T21:08:04.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":495000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":495000,"derivative":{"exercise_price":14.15,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":495000},"source":{"system":"sec-edgar","filing":"0001209191-22-005360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919122005360/doc4.xml","form_type":"4"}},{"id":2663419,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-18T01:11:46.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":27858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":28208,"source":{"system":"sec-edgar","filing":"0001209191-21-041803","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121041803/doc4.xml","form_type":"4"}},{"id":2665546,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T00:11:51.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":26.09,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-041153","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000120919121041153/doc4.xml","form_type":"4"}},{"id":2671716,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-11T23:30:44.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":25748,"price":11.3575,"value":292432.91,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.24 to $11.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":350,"source":{"system":"sec-edgar","filing":"0001209191-21-040041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121040041/doc4.xml","form_type":"4"}},{"id":2892057,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2021-01-28T22:16:30.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":366500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":366500,"derivative":{"exercise_price":32.8,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":366500},"source":{"system":"sec-edgar","filing":"0001209191-21-005903","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919121005903/doc4.xml","form_type":"4"}},{"id":2892056,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-28T22:16:30.000Z","date":"2020-12-23","kind":"other","acquired":false,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Red Fish Blue Fish Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This line item reflects a transfer of 175,000 shares of common stock of Kura Oncology, Inc. (the \"Shares\") held by a grantor trust established by the reporting person to an incomplete non-grantor trust for estate planning purposes. As a consequence of this transfer, the reporting person will no longer have beneficial ownership of the Shares."}],"balance_after":1620017,"source":{"system":"sec-edgar","filing":"0001209191-21-005903","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919121005903/doc4.xml","form_type":"4"}},{"id":2930779,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T21:49:24.000Z","date":"2020-12-22","kind":"other","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By family trust 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer for no value from the Reporting Person to a trust established for the benefit of the Reporting Person's family."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-20-065194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000120919120065194/doc4.xml","form_type":"4"}},{"id":2930778,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T21:49:24.000Z","date":"2020-12-22","kind":"other","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer for no value from the Reporting Person to a trust established for the benefit of the Reporting Person's family."}],"balance_after":89618,"source":{"system":"sec-edgar","filing":"0001209191-20-065194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000120919120065194/doc4.xml","form_type":"4"}},{"id":2960550,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2020-12-02T21:04:01.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":11855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents options exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on 1/23/2017."}],"balance_after":90210,"derivative":{"exercise_price":6.15,"expiration_date":"2027-01-22","underlying":"Common Stock","underlying_shares":11855},"source":{"system":"sec-edgar","filing":"0001209191-20-061111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120061111/doc4.xml","form_type":"4"}},{"id":2960549,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-02T21:04:01.000Z","date":"2020-12-01","kind":"exercise","acquired":true,"shares":11855,"price":6.15,"value":72908.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents options exercised."}],"balance_after":39951,"source":{"system":"sec-edgar","filing":"0001209191-20-061111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120061111/doc4.xml","form_type":"4"}},{"id":3009951,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2020-10-08T22:55:00.000Z","date":"2020-10-08","kind":"exercise","acquired":false,"shares":50370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 equal monthly installments commencing on January 23, 2017."}],"balance_after":102065,"derivative":{"exercise_price":6.15,"expiration_date":"2027-01-22","underlying":"Common Stock","underlying_shares":50370},"source":{"system":"sec-edgar","filing":"0001209191-20-054328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120054328/doc4.xml","form_type":"4"}},{"id":3009950,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2020-10-08T22:55:00.000Z","date":"2020-10-07","kind":"exercise","acquired":false,"shares":4586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 equal monthly installments commencing on January 23, 2017."}],"balance_after":152435,"derivative":{"exercise_price":6.15,"expiration_date":"2027-01-22","underlying":"Common Stock","underlying_shares":4586},"source":{"system":"sec-edgar","filing":"0001209191-20-054328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120054328/doc4.xml","form_type":"4"}},{"id":3009949,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-08T22:55:00.000Z","date":"2020-10-08","kind":"sale","acquired":false,"shares":50370,"price":34,"value":1712580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020."}],"balance_after":28096,"source":{"system":"sec-edgar","filing":"0001209191-20-054328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120054328/doc4.xml","form_type":"4"}},{"id":3009948,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-08T22:55:00.000Z","date":"2020-10-08","kind":"exercise","acquired":true,"shares":50370,"price":6.15,"value":309775.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020."}],"balance_after":78466,"source":{"system":"sec-edgar","filing":"0001209191-20-054328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120054328/doc4.xml","form_type":"4"}},{"id":3009947,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-08T22:55:00.000Z","date":"2020-10-07","kind":"sale","acquired":false,"shares":4586,"price":34,"value":155924.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020."}],"balance_after":28096,"source":{"system":"sec-edgar","filing":"0001209191-20-054328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120054328/doc4.xml","form_type":"4"}},{"id":3009946,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-08T22:55:00.000Z","date":"2020-10-07","kind":"exercise","acquired":true,"shares":4586,"price":6.15,"value":28203.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020."}],"balance_after":32682,"source":{"system":"sec-edgar","filing":"0001209191-20-054328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120054328/doc4.xml","form_type":"4"}},{"id":3009945,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-08T22:55:00.000Z","date":"2020-10-08","kind":"sale","acquired":false,"shares":106736,"price":34,"value":3629024.0,"ownership":{"direct":false,"nature":"by Araxes Pharma LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-054328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120054328/doc4.xml","form_type":"4"}},{"id":3009944,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-08T22:55:00.000Z","date":"2020-10-07","kind":"sale","acquired":false,"shares":99900,"price":32,"value":3196800.0,"ownership":{"direct":false,"nature":"by Araxes Pharma LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020."}],"balance_after":106736,"source":{"system":"sec-edgar","filing":"0001209191-20-054328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120054328/doc4.xml","form_type":"4"}},{"id":3009943,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-08T22:55:00.000Z","date":"2020-10-06","kind":"sale","acquired":false,"shares":100,"price":32,"value":3200.0,"ownership":{"direct":false,"nature":"by Araxes Pharma LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020."}],"balance_after":206636,"source":{"system":"sec-edgar","filing":"0001209191-20-054328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120054328/doc4.xml","form_type":"4"}},{"id":3031244,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2020-09-15T23:22:28.000Z","date":"2020-09-11","kind":"exercise","acquired":false,"shares":17926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in 48 equal monthly installments commencing on January 23, 2017."}],"balance_after":157021,"derivative":{"exercise_price":6.15,"expiration_date":"2027-01-22","underlying":"Common Stock","underlying_shares":17926},"source":{"system":"sec-edgar","filing":"0001209191-20-050590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120050590/doc4.xml","form_type":"4"}},{"id":3031243,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-15T23:22:28.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":98490,"price":28.824,"value":2838875.76,"ownership":{"direct":false,"nature":"by Araxes Pharma LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $28.00 to $29.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":206736,"source":{"system":"sec-edgar","filing":"0001209191-20-050590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120050590/doc4.xml","form_type":"4"}},{"id":3031242,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-15T23:22:28.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":485,"price":28,"value":13580.0,"ownership":{"direct":false,"nature":"by Araxes Pharma LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020."}],"balance_after":305226,"source":{"system":"sec-edgar","filing":"0001209191-20-050590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120050590/doc4.xml","form_type":"4"}},{"id":3031241,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-15T23:22:28.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":17926,"price":28,"value":501928.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020."}],"balance_after":28096,"source":{"system":"sec-edgar","filing":"0001209191-20-050590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120050590/doc4.xml","form_type":"4"}},{"id":3031240,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-15T23:22:28.000Z","date":"2020-09-11","kind":"exercise","acquired":true,"shares":17926,"price":6.15,"value":110244.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020."}],"balance_after":46022,"source":{"system":"sec-edgar","filing":"0001209191-20-050590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120050590/doc4.xml","form_type":"4"}},{"id":3034318,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase common stock","published_at":"2020-09-10T22:05:53.000Z","date":"2020-09-10","kind":"exercise","acquired":false,"shares":37030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 equal monthly installments commencing on January 23, 2017."}],"balance_after":174947,"derivative":{"exercise_price":6.15,"expiration_date":"2027-01-22","underlying":"Common Stock","underlying_shares":37030},"source":{"system":"sec-edgar","filing":"0001209191-20-050028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120050028/doc4.xml","form_type":"4"}}],"next_cursor":"2020-09-10T22:05:53.000000Z,3034318"}